Duke University researchers identify new coronavirus threat to humans EP News Bureau May 20, 2021 The virus appeared to have jumped from dogs to humans
Bacteria, viruses, and fungi work as a network in causing lung infection: Study EP News Bureau May 20, 2021 Researchers from NTU Singapore find that microbes in the body exist as a network, and that an infection’s severity could be a…
ISCR lauds clinical research stakeholders on International Clinical Trials Day EP News Bureau May 19, 2021 New models of clinical trials were effectively developed to ensure continuity of trials in a pandemic environment without…
IIT Madras, MIT researchers develop human brain tissues from 3D printed bioreactor EP News Bureau May 18, 2021 Objective is to observe brain tissues while they grow and develop a technology that can potentially accelerate medical and…
SPARC declares positive results from Phase 3 clinical trial of PDP-716 to treat open-angle glaucoma… EP News Bureau May 14, 2021 The primary endpoint of the trial was to evaluate the efficacy of once daily (QD) dosing of PDP-716 0.35 per cent compared with…
Beyond the pandemic: Building collaborative media engagement for clinical research EP News Bureau May 8, 2021 Melissa Arulappan, Head, Corporate Communications, IQVIA India elaborates on the learnings for journalists from the pandemic to…
Clinical trials resume but still impacted by slow enrollment: GlobalData EP News Bureau May 6, 2021 There is also a high risk to subjects in a clinical trial who have serious chronic or acute condition that affects their immune…
Cell therapy for solid tumors may get approval by 2022: GlobalData EP News Bureau May 1, 2021 A total of 298 industry-sponsored trials are currently ongoing investigating cell therapies in non-haematological cancers, says…
Syngene extends research partnership with Bristol Myers Squibb until 2030 EP News Bureau Apr 27, 2021 The extension envisions a 40 per cent increase in the number of scientists and the addition of a new 50,000 sq. ft. dedicated…
Virus therapy shows promise against inoperable skin cancers EP News Bureau Apr 10, 2021 The drug combination is among the first, researchers say, to demonstrate the potential value of a live common cold virus,…
Research identifies novel peptoids with potent antiviral activity against HSV-1 and SARS-CoV-2 EP News Bureau Apr 6, 2021 Antiviral peptoids are being developed by Maxwell Biosciences to treat recurrent herpes labialis
Novavax allows giving COVID-19 vaccine to trial participants on placebo Reuters Apr 6, 2021 Allowing volunteers to crossover to the active vaccine offers them an incentive to continue in the trials even when other…
Prioritising who receives COVID-19 vaccine first saves lives: Research Press Trust of India Apr 5, 2021 They found that deaths, years of life lost and infections were between 17 and 44 per cent lower when vaccinations targeted…
Research identifies nine potential new COVID-19 treatments IANS Apr 4, 2021 Three already have FDA approval — the transplant-rejection drug cyclosporine, the cancer drug dacomitinib, and the antibiotic…
Private genomics industry may be called upon to speed up strategic genome surveillance initiatives Lakshmipriya Nair Apr 2, 2021 Clevergene, a tech company, offers genomics services for contract research and genetic diagnostics. In an interview, Tony Jose,…
MIMS Research Foundation is developing a novel drug to treat coronavirus Usha Sharma Mar 31, 2021 The company have repurposed its sepsis research for COVID management
Resumed clinical trials will grow gradually with COVID-19 vaccine rollout: GlobalData EP News Bureau Mar 30, 2021 As of February 22, 2021, the number of resumed trials has increased to 955
Bharat Biotech, Biovet, Sapigen Biologix enter into research pact with CSIR-IICT EP News Bureau Mar 29, 2021 To collaborate on the development of novel platform technologies for biotherapeutics and vaccines to support indigenous,…
300 per cent increase in companies conducting endometriosis clinical trials since 2010: GlobalData EP News Bureau Mar 29, 2021 Bayer, Ferring International and AbbVie were among the most highly active sponsors with 21, 11 and seven trials, respectively
Animal research facility opens at JNU Reuters Mar 25, 2021 A new "state-of-the-art" animal research facility was inaugurated at the Jawaharlal Nehru University on Tuesday. According to a…